Continuous-use ethinylestradiol/levonorgestrel 20μg/90μg: As an oral contraceptive

Drugs

Volumn 67, Issue 16, 2007, Pages 2473-2477

  Wagstaff, Antona J ^a  

^a Wolters Kluwer Health   (New Zealand)

Author keywords

Adis Drug Profiles; Contraception; Ethinylestradiol levonorgestrel, general

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; LYBREL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACCIDENTAL INJURY; ACNE VULGARIS; AMENORRHEA; BACKACHE; BLEEDING; CHOLECYSTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; DYSMENORRHEA; ECTOPIC PREGNANCY; FLU LIKE SYNDROME; HEADACHE; HUMAN; LUNG EMBOLISM; MASTALGIA; MENSTRUATION; METRORRHAGIA; MULTIPLE CYCLE TREATMENT; NAUSEA; ORAL CONTRACEPTION; OVULATION; PHARYNGITIS; PREGNANCY RATE; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINITIS; SEXUAL BEHAVIOR; SINUSITIS; ULTRASOUND; UPPER RESPIRATORY TRACT INFECTION; UTERUS BLEEDING; UTERUS MYOMA; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINITIS;

EID: 35948965268     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767160-00009     Document Type: Review

References (9)

1. Wyeth Pharmaceuticals Inc. Lybrel™ (90 mcg levonorgestrel and 20 mcg ethinyl estradiol) tablets; prescribing information [online]. Available from URL: http://www.wyeth.com [Accessed 2007 Jun 12]
2. Johnson JV, Grubb GS, Constantine GD. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg. Contraception 2007 Jan; 75 (1): 23-6
3. Archer DF, Jensen JT, Johnson JV, et al. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 2006 Dec; 74 (6): 439-45
4. Archer DF, Kovalevsky G, Ballagh S, et al. Effect on ovarian activity of a continuous-use regimen of oral levonorgestrel/ethinyl estradiol [abstract no. O-57]. Fertil Steril 2005 Sep; 84 Suppl. 1: S24
5. Davis AR, Kroll R, Soltes B, et al. Return to menses after continuous use of a low-dose oral contraceptive [abstract]. Obstet Gynecol 2006 Apr; 107 (4 Suppl.): 3S
6. Barnhart A, Mirkin S, Grubb G, et al. Return of fertility after cessation of a continuous oral contraceptive [abstract no. O-34]. Fertil Steril 2006 Sep; 86 Suppl. 2: S15
7. Freeman EW, Borisute H, Deal L, et al. A continuous-use regimen of levonorgestrel/ethinyl estradiol significantly alleviates cycle-related symptoms: results of a phase 3 study [abstract no. O-59]. Fertil Steril 2005 Sep; 84 Suppl. 1: S25
8. Teichmann AT, Kluft C, Grubb G, et al. Comparative trial of continuous-use and 21-day cyclic levonorgestrel and ethinyl estradiol oral contraceptive [abstract]. Obstet Gynecol 2006 Apr; 107 (4 Suppl.): 12S
9. Reid R, Fortier M, Mirkin S. Two-year experience with a continuous low-dose oral contraceptive in Canada [abstract]. Annual Meeting of the Society of Obstetricians and Gynecologists of Canada; 2006 Jun 22-27; Vancouver (BC)